Emerson Names Dr. Candace Kendle to Board of Directors
ST. LOUIS -- February 4, 2014
Candace Kendle, retired chairman and chief executive officer of Kendle
International Inc., has been elected to Emerson’s (NYSE:EMR) board of
directors, Chairman and CEO David N. Farr announced today.
Dr. Kendle co-founded Kendle International Inc., a global clinical research
organization that provides a wide range of services to the global
biopharmaceutical industry. She served as its chairman and CEO from 1981 to
2011, growing Kendle International into a $450-million public company and a
leader in its industry, prior to its acquisition by INC Research in 2011.
Before founding Kendle International, she held faculty positions with a number
of leading universities, including the University of Cincinnati College of
Pharmacy, the University of Pennsylvania School of Medicine, and the
University of North Carolina School of Medicine and School of Pharmacy.
“We are pleased that Dr. Kendle will be joining the board and we look forward
to her contributions and the benefits to Emerson that her keen insights and
strong global business experience will bring us,” said Farr.
Throughout her career, Kendle has been active with civic, educational, and
professional organizations. In 2008, she founded ReadAloud.org, a non-profit
organization aimed at improving childhood literacy by making reading aloud for
fifteen minutes per day the standard in childcare.
Dr. Kendle is a director of United Parcel Service (UPS), serving on the
company’s Audit Committee and as a healthcare expert to the board. Dr. Kendle
also previously served on the board of directors of H. J. Heinz Company, and
was a member of its Audit Committee and Corporate Governance Committee.
Additionally, she has served on the boards of such organizations as the
University of Cincinnati Foundation, the Harvard Business School Alumni
Association, and the National Underground Railroad Freedom Center of the
Dr. Kendle holds a doctorate in pharmacy from the University of Cincinnati,
and completed her post-doctoral training at the Cincinnati Children’s Hospital
Medical Center and the University of North Carolina School of Public Health.
She will serve on the Emerson Board’s Corporate Governance and Nominating
Committee and Finance Committee.
Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in
bringing technology and engineering together to provide innovative solutions
for customers in industrial, commercial, and consumer markets around the
world. The company comprises five business segments: Process Management,
Industrial Automation, Network Power, Climate Technologies, and Commercial &
Residential Solutions. Sales in fiscal 2013 were $24.7 billion. For more
information, visit www.Emerson.com.
Mark Polzin, 314-982-1758
Press spacebar to pause and continue. Press esc to stop.